Rigel Pharmaceuticals, Inc. (RIGL)

30.34 -0.13 (-0.43%) USD  |  NASDAQ  |  Apr 23, 10:56
More

Rigel Pharmaceuticals Outperform Recommendations

Outperform Recommendations Chart

View Outperform Recommendations for RIGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Outperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Outperform Recommendations Range, Past 5 Years

View Outperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Outperform Recommendations Benchmarks

View Outperform Recommendations Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Nektar Therapeutics Upgrade
Madrigal Pharmaceuticals, Inc. Upgrade